Clinical Trial Update: S-1, Irinotecan, and Oxaliplatin in Locally-Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the combination of S-1, irinotecan, and oxaliplatin in locally-advanced pancreatic ductal adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Pancreatic Ductal Adenocarcinoma | Phase 2 | Status: UNKNOWN